Adare Pharma Solutions purchases Frontida BioPharm
Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing
Lonza and Bioqube sign biologics agreement
Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates
GreenLight Biosciences, Samsung Biologics partner up to develop Covid vaccine candidate
Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale
People spotlight — November 2021
The latest people news happenings over the past month
Five powerful Covid-related shifts in patient care
The biggest areas of adjustment in patient support brought on by changes in consumer and physician behavior
AstraZeneca opens new $1.3 billion R&D plant
The Discovery Centre will be powered by AI technology, robotics, among other features
Novo Nordisk inks $3.3 billion deal for Dicerna Pharma
Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics
Merck purchases Acceleron Pharma for $11.5 billion
Acquisition of biopharma company features sotatercept, which is in Phase III trials for the treatment of pulmonary arterial hypertension
Sterling Pharma Solutions unveils $13.4 million investment plan for Dudley, UK site
Financial commitment expected to increase plant's process development and manufacturing capacity
FDA authorizes emergency use of Moderna booster in individuals 18 and older
Approval is for the 50-µg dosage
UPS Healthcare adds reusable packaging to its cold chain services
Opens a ‘Cold Chain Packaging Center of Excellence’ in Kentucky, while expanding services globally
Deloitte and Sanofi collaborate on artificial intelligence SaaS platform
ConvergeHEALTH Safety intended to automate pharmacovigilance case processing
J&J to branch out its consumer health business
Separation process expected to be completed in 18-24 months
Califf nominated to head FDA
White House announces official endorsement, paving way for Senate confirmation process
Generic drugmakers also fight price controls
It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates
Fujifilm Irvine Scientific further develops its Armstrong R&D Cell Culture Center of Excellence
Expansion expected to more than double the plant’s footprint
NCPA survey: Independent pharmacies impacted by supply chain, labor disruptions
PBM fees and vertical integration are also at the top of the list
Lykan Bioscience to grow its cell therapy manufacturing capabilities
CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites
Sever Pharma Solutions purchases Foster Delivery Science
Deal expected to boost firm’s offerings via FDS's delivery system services
The Vistria Group acquires BioCare
Partnership further increases investment firm’s repertoire in healthcare space
PCI Pharma Services to construct Clinical Center of Excellence
Boston area facility will focus heavily on cold chain services
Thread acquires Modus Outcomes in DCT deal
Parties expect improved design and selection of eCOAs in decentralized clinical trials
IATA unveils September air cargo numbers
Latest report shows that demand is above pre-crisis numbers, but there are still capacity constraints
CDC signs off on pediatric Covid vaccine for young children ages 5 to 11
Centers for Disease Control and Prevention endorses Pfizer-BioNTech jab, less than two months after firms presented positive study results
The pace of DSCSA readiness preparations has slowed, says annual HDA survey
Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023
Partnership tackles barriers to drug adherence
ScriptDrop, Adheris Health collaborate to assist patients with their medication regimens
WuXi Biologics debuts new commercial drug product plant
Anticipated capacity of GMP facility is 60 million vials per year
Moderna to provide an additional 56.5 million vaccine doses to Gavi
A total of 116.5 million doses for low- and middle-income nations to arrive in Q2 of 2022
Cardinal Health granted FDA funding for RWE study
Award will support research based on use of real-world evidence in clinical oncology setting
People spotlight — October 2021
